Pharmacodynamic interactions between infused adenosine and oral theophylline.
1. Five healthy human subjects were given, in single-blind fashion, either (a) 625 mg theophylline orally, followed 4 h later, by a 40 min infusion of adenosine (40 micrograms kg-1 min-1 for 5 min, 60 micrograms kg-1 min-1 for 5 min and 80 micrograms kg-1 min-1 for 30 min), or (b) 625 mg theophylline orally followed by 0.9% sodium chloride infusion, or (c) placebo theophylline tablets followed by adenosine infusion. 2. All five subjects experienced adverse effects during adenosine infusion, mainly at the higher infusion rates; two subjects also experienced chest pain but not during combined treatment with theophylline and adenosine. 3. Diastolic blood pressure (DBP) rose by 16.5 mmHg (P less than 0.001) following treatment with theophylline only, fell by 24.5 mmHg (P less than 0.001) during the adenosine infusion after placebo theophylline and remained unchanged during the adenosine infusion following theophylline. Pulse rate rose by 12 min-1 (P less than 0.01) during adenosine infusion following placebo, but not after theophylline alone or theophylline and adenosine combined. 4. The respiratory rate fell by 6 min-1 (P less than 0.01) during treatment with adenosine only, being lower than for the two treatments containing theophylline (P less than 0.05). 5. Plasma potassium and magnesium fell by 0.25 mmol l-1 (P less than 0.001) and 0.037 mmol l-1 (P less than 0.05), respectively, during treatment with theophylline only, but these effects were not altered by infusion of adenosine. 6. This study has demonstrated interactions between theophylline and adenosine on diastolic blood pressure and respiratory rate, but no interaction on metabolic parameters.(ABSTRACT TRUNCATED AT 250 WORDS)
Minton
N A
NA
National Poisons Unit, Guy's Hospital, London, UK.
Henry
J A
JA
D000241:Adenosine / Q000009:adverse effects / Q000494:pharmacology*; D000284:Administration, Oral; D000328:Adult; D001786:Blood Glucose / Q000187:drug effects; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008274:Magnesium / Q000097:blood; D008297:Male; D011188:Potassium / Q000097:blood; D011674:Pulse / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013806:Theophylline / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*
D001786:Blood Glucose; D013806:Theophylline; D008274:Magnesium; D000241:Adenosine; D011188:Potassium